Volume 10, Issue 5 , Pages 494-500, May 2012
Factors Associated With Persistent and Nonpersistent Chronic Constipation, Over 20 Years
Background & Aims
The prevalence of chronic constipation (CC) has been reported to be as high as 20% in the general population, but little is known about its natural history. We estimated the natural history of CC and characterized features of persistent CC and nonpersistent CC, compared with individuals without constipation.
Methods
In a prospective cohort study, we analyzed data collected from multiple, validated surveys (minimum of 2) of 2853 randomly selected subjects, over a 20-year period (median, 11.6 years). Based on responses, subjects were characterized as having persistent CC, nonpersistent CC, or no constipation. We assessed the association between constipation status and potential risk factors using logistic regression models, adjusting for age and sex.
Results
Of the respondents, 84 had persistent CC (3%), 605 had nonpersistent CC (21%), and 2164 had no symptoms of constipation (76%). High scores from the somatic symptom checklist (odds ratio [OR] = 2.1; 95% confidence interval [CI], 1.3–3.4) and frequent doctor visits (OR = 2.0; 95% CI, 1.0–3.8) were significantly associated with persistent CC, compared with subjects with no constipation symptoms. The only factor that differed was increased use of laxatives or fiber among subjects with persistent CC (OR = 3.0; 95% CI, 1.9–4.9).
Conclusions
The prevalence of constipation might be exaggerated—the proportion of the population with persistent CC is low (3%). Patients with persistent and nonpersistent CC have similar clinical characteristics, although individuals with persistent CC use more laxatives or fiber. CC therefore appears and disappears among certain patients, but we do not have enough information to identify these individuals in advance.
Keywords: SSC , Epidemiology , Determinants , Diagnosis
Abbreviations used in this paper: BDQ, Bowel Disease Questionnaire, BM, bowel movement, BMI, body mass index, CC, chronic constipation, CI, confidence interval, GI, gastrointestinal, IBS, irritable bowel syndrome, OR, odds ratio, SSC, Somatic Symptom Checklist
To access this article, please choose from the options below
Watch this article's video abstract and others at http://tiny.cc/bz9jv.
Conflicts of interest This author discloses the following: Dr Talley and Mayo Clinic have licensed the Talley Bowel Disease Questionnaire. The remaining authors disclose no conflicts.
Funding This study was sponsored by Takeda Pharmaceuticals and was made possible by the Rochester Epidemiology Project (Grant R01-AG034676 from the National Institute on Aging).
PII: S1542-3565(12)00115-2
doi:10.1016/j.cgh.2011.12.041
© 2012 AGA Institute. Published by Elsevier Inc. All rights reserved.
Volume 10, Issue 5 , Pages 494-500, May 2012

